Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women

Ollin Celeste Martínez‐Ramírez, Rebeca Pérez–Morales, Célio José de Castro, Alan Flores-Díaz, K.E. Soto-Cruz, Alma Magdalena Astorga-Ramos, María E. Gonsebatt, L. Casas, Margarita Valdés‐Flores, José Luis Rubio

The Breast · 2012 · 40 citations · 57 references

DOIFull text

Open access

Concepts

Abstract

Breast cancer is associated to estrogen exposure. Allelic variants involved in estrogen metabolism might change the risk of developing this neoplasia. We examined the potential association of breast cancer risk in Mexican women with the polymorphisms CYP1A1 rs1048943, CYP1B1 rs1056836, COMT rs4680, GSTP1 rs1695, GSTT1 null and GSTM1 null which are involved in estrogen metabolism pathway. This study included 150 cases and 150 controls. A significant association was observed between, CYP1A1 rs1048943 (OR = 1.95, C.I. 1.13-3.36) and GSTP1 rs1695 (OR = 2.39, C.I. 1.24-4.24) polymorphisms with the risk of breast cancer. This risk was increased when the women were stratified according to their menopausal status. The results show that breast cancer risk significantly increases in women with 3-6 risk polymorphisms (OR = 3.75, C.I. 1.44-9.74).

References

57